TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Transient Receptor Potential Cation (TRPC) channels are expressed in the nervous system, but their precise functions are not fully understood.
• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques, and cognitive deficits, but the role of TRPC channels in AD pathogenesis is unclear.

Purpose of the Study:

• To investigate the role of TRPC1 in cognitive function and neuronal apoptosis, particularly in the context of amyloid-beta (Aβ) induced pathology.
• To elucidate the molecular mechanism by which TRPC1 interacts with amyloid-beta protein precursor (AβPP) and influences Aβ production.

Main Methods:

• Utilized TRPC1 knockout mouse models to assess learning and memory.
• Investigated Aβ-induced cell apoptosis in mouse hippocampus and cell models.
• Analyzed TRPC1 and AβPP levels in AD cell and mouse models.
• Examined the interaction between TRPC1 and AβPP using molecular biology techniques.

Main Results:

• TRPC1 deletion did not impair learning, memory, or cause apoptosis under physiological conditions.
• TRPC1 deficiency exacerbated Aβ-induced learning deficits and hippocampal cell death.
• TRPC1 levels were reduced in AD models, and TRPC1 upregulation decreased Aβ levels and apoptosis.
• The transmembrane domain of TRPC1 directly binds to AβPP, reducing Aβ production.

Conclusions:

• TRPC1 plays a protective role against Aβ-induced neurotoxicity and cognitive decline in Alzheimer's disease.
• Loss of TRPC1 function exacerbates AD pathology by increasing Aβ production and neuronal apoptosis.
• TRPC1 represents a potential therapeutic target for mitigating Aβ-related neurodegeneration in AD.